Boston Scientific, which announced a €21.7m investment in its Cork plant last August, has reported an almost 40% fall in its second quarter earnings.
Income went from €123m to €76m compared to the same period last year. Boss of the medical-devices maker Ray Elliott said sales of new products were very encouraging.
Some 44% of our sales in the quarter came from new products, a testament to the strength of their research, he said.
Article courtesy of the Evening Echo newspaper.